Teleflex (TFX) Stock Price, News & Analysis

Company Overview

Teleflex Incorporated is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, physicians and other healthcare providers. Its products are designed to support minimally invasive procedures, critical care and a range of clinical applications.

The company’s portfolio includes devices for vascular access and intervention, anesthesia, respiratory care, emergency medicine, surgery, urology and pain management. Teleflex markets products under brands including Arrow, which is known for vascular access and catheter-based technologies, as well as other specialized product lines used in hospitals and outpatient settings.

Teleflex serves healthcare markets in North America, Europe, Asia and other international regions. The company traces its roots to the 1940s and has expanded its medical technology business through internal development and acquisitions, including the addition of Vascular Solutions and Z-Medica.

Key Stats

• Today's Range: $123.05 to $126.56
• 50-Day Range: $120.15 to $142.08
• 52-Week Range: $100.18 to $145.00
• Volume: 552,365 shs
• Average Volume: 862,741 shs
• Market Capitalization: $5.27 billion
• P/E Ratio: N/A
• Dividend Yield: 1.09%
• Price Target: $155.20
• Consensus Rating: Moderate Buy

Teleflex Stock Analysis - MarketRank™

Teleflex scored higher than 82% of companies evaluated by MarketBeat, and ranked 84th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Teleflex has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 strong buy ratings, 5 buy ratings, 4 hold ratings, and 1 sell rating.

Upside Potential

Teleflex has a consensus price target of $155.20, representing about 24.7% upside from its current price of $124.44.

Amount of Analyst Coverage

Teleflex has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 50.83%

Earnings Growth

Earnings for Teleflex are expected to grow by 50.83% in the coming year, from $7.22 to $10.89 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teleflex is -5.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teleflex is -5.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Teleflex has a PEG Ratio of 0.84. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Teleflex has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.63% of the float of Teleflex has been sold short.

Short Interest Ratio / Days to Cover

Teleflex has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Teleflex has recently increased by 1.22%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Teleflex pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Teleflex does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Teleflex will have a dividend payout ratio of 12.49% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: 0.00

News Sentiment

Teleflex has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Teleflex this week, compared to 6 articles on an average week.

MarketBeat Follows

Only 1 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Teleflex insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.70% of the stock of Teleflex is held by insiders.

Percentage Held by Institutions

95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Record date for 9/30 Dividend: 8/14/2026
• Ex-Dividend for 9/30 Dividend: 8/14/2026
• Dividend Payable: 9/30/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:TFX
• CIK: 96943
• Web: www.teleflex.com
• Phone: (610) 225-6800
• Fax: 215-553-5402
• Employees: 15,500
• Year Founded: 1943

Price Target and Rating

• Average Price Target for Teleflex: $155.20
• High Price Target: $170.00
• Low Price Target: $138.00
• Potential Upside/Downside: +24.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): ($23.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 17.24
• P/E Growth: 0.84
• Net Income: -$905.64 million
• Net Margins: -39.67%
• Pretax Margin: -2.44%
• Return on Equity: 11.93%
• Return on Assets: 5.44%

Debt

• Debt-to-Equity Ratio: 0.94
• Current Ratio: 2.60
• Quick Ratio: 2.12

Sales & Book Value

• Annual Sales: $1.99 billion
• Price / Sales: 2.65
• Cash Flow: $11.08 per share
• Price / Cash Flow: 11.23
• Book Value: $70.71 per share
• Price / Book: 1.76

Miscellaneous

• Outstanding Shares: 42,370,000
• Free Float: 42,075,000
• Market Cap: $5.27 billion
• Optionable: Optionable
• Beta: 0.83